Sayre, Peter H.

Randomized trial of peanut consumption in infants at risk for peanut allergy

Du Toit, G., Roberts, G., Sayre, P. H., Bahnson, H. T., Radulovic, S., Santos, A. F., Brough, H. A., Phippard, D., Basting, M., Feeney, M., et al. (2015) · New England Journal of Medicine

Food Allergy and Anaphylaxis ResearchDrug-Induced Adverse Reactions

Cited by 2,237

Type 1 diabetes immunotherapy using polyclonal regulatory T cells

Bluestone, J. A., Buckner, J. H., Fitch, M., Gitelman, S. E., Gupta, S., Hellerstein, M. K., Herold, K. C., Lares, A., Lee, M. R., Li, K., et al. (2015) · Science Translational Medicine

Diabetes and associated disordersT-cell and B-cell Immunology

Cited by 1,033

Treatment of patients with new onset type 1 diabetes with a single course of anti-CD3 mAb teplizumab preserves insulin production for up to 5 years

Herold, K. C., Gitelman, S., Greenbaum, C., Puck, J., Hagopian, W., Gottlieb, P., Sayre, P., Bianchine, P., Wong, E., Seyfert-Margolis, V., et al. (2009) · Clinical Immunology

Diabetes and associated disordersT-cell and B-cell Immunology

Cited by 219

Long-Term Follow-Up of the Edmonton Protocol of Islet Transplantation in the United States

Brennan, D. C., Kopetskie, H. A., Sayre, P. H., Alejandro, R., Cagliero, E., Shapiro, A. M. J., Goldstein, J. S., DesMarais, M. R., Booher, S., & Bianchine, P. J. (2016) · American Journal of Transplantation

Pancreatic function and diabetesDiabetes and associated disorders

Cited by 176

Inhibition of MET Signaling with Ficlatuzumab in Combination with Chemotherapy in Refractory AML: Clinical Outcomes and High-Dimensional Analysis

Wang, V. E., Blaser, B. W., Patel, R. K., Behbehani, G. K., Rao, A. A., Durbin-Johnson, B., Jiang, T., Logan, A. C., Settles, M., Mannis, G. N., et al. (2021) · Blood Cancer Discovery

Acute Myeloid Leukemia ResearchRetinoids in leukemia and cellular processes

Cited by 11